Lippis Daniel J.

Lippis Daniel J. serves as Chief Vice President (CVP) at Edwards Lifesciences Corporation, a leading company in the healthcare sector focused on innovative heart valve therapies and hemodynamic monitoring. His recent trading record includes 15 disclosures from May 4, 2026, to June 30, 2026, all related to his role at Edwards Lifesciences (EW), primarily reflecting sale activities. The disclosed amounts range from $56.6K to $50.3K, with the largest reported move being a grant/exercise valued at approximately $3.3 million on May 8, 2026.